candesartan has been researched along with curcumin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Awad, AS | 1 |
3 other study(ies) available for candesartan and curcumin
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effect of combined treatment with curcumin and candesartan on ischemic brain damage in mice.
Topics: Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Brain; Cerebrovascular Circulation; Curcumin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Glutathione Transferase; Heart Rate; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Male; Mice; Neuroprotective Agents; Regional Blood Flow; Superoxide Dismutase; Tetrazoles; Time Factors | 2011 |